世界の骨転移治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bone Metastasis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0947 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、骨転移治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、腫瘍アブレーション療法、手術）、用途別市場規模（病院、がんリハビリセンター、専門クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・骨転移治療の市場動向 ・企業の競争状況、市場シェア ・骨転移治療の種類別市場規模（薬物治療、腫瘍アブレーション療法、手術） ・骨転移治療の用途別市場規模（病院、がんリハビリセンター、専門クリニック、外来手術センター） ・骨転移治療の北米市場規模2016-2027（アメリカ、カナダ） ・骨転移治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・骨転移治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・骨転移治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・骨転移治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche、Bayer、Merck、Pfizer、Novartis、Amgen、Pharmalucence、Fresenius Kabi、Omega Laboratories、Eli Lilly） ・結論

Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic cancers are rarely able to be cured, and treatment of bone metastasis involves medications to shrink, stop or slow down the growth of the tumor. Treatment options available for bone metastasis are symptomatic treatments which are meant for pain control, treatment, and prevention of fractures, improvement in functional disability, etc. Randomized trials on metastatic patients by UBM Medica, LLC showed that 45-75% patients develop functional disability every 3-4 months, 10-15% patients develop hypercalcemia and 10-20% patients develop long bone fractures. 
Treatment of bone metastasis is the interdisciplinary field involving pain management, orthopedics, and other medical specialties. Primary factors driving the growth of bone metastasis therapeutics market are the global increase in cancer prevalence and delayed diagnosis of cancer in low-income countries. According to University of Texas Southwestern Medical Center Dallas, over 600,000 of bone metastasis are diagnosed in the U.S. every year. Rapid innovation in the field of personalized medicine and identification of new therapeutic targets for bone metastasis presents a huge opportunity to manufacturers of targeted therapy agents. A large number of treatment methods are still under investigation. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global bone metastasis therapeutics market.

Market Analysis and Insights: Global Bone Metastasis Therapeutics Market
The global Bone Metastasis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bone Metastasis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bone Metastasis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bone Metastasis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bone Metastasis Therapeutics market.

Global Bone Metastasis Therapeutics Scope and Market Size
Bone Metastasis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Metastasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Treatment
Tumor Ablation Therapy
Surgery

Segment by Application
Hospitals
Cancer Rehabilitation Centers
Specialty Clinics
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche
Bayer
Merck
Pfizer
Novartis
Amgen
Pharmalucence
Fresenius Kabi
Omega Laboratories

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Metastasis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Tumor Ablation Therapy
1.2.4 Surgery
1.3 Market by Application
1.3.1 Global Bone Metastasis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Rehabilitation Centers
1.3.4 Specialty Clinics
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bone Metastasis Therapeutics Market Perspective (2016-2027)
2.2 Bone Metastasis Therapeutics Growth Trends by Regions
2.2.1 Bone Metastasis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bone Metastasis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bone Metastasis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bone Metastasis Therapeutics Industry Dynamic
2.3.1 Bone Metastasis Therapeutics Market Trends
2.3.2 Bone Metastasis Therapeutics Market Drivers
2.3.3 Bone Metastasis Therapeutics Market Challenges
2.3.4 Bone Metastasis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bone Metastasis Therapeutics Players by Revenue
3.1.1 Global Top Bone Metastasis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bone Metastasis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bone Metastasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bone Metastasis Therapeutics Revenue
3.4 Global Bone Metastasis Therapeutics Market Concentration Ratio
3.4.1 Global Bone Metastasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone Metastasis Therapeutics Revenue in 2020
3.5 Bone Metastasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Bone Metastasis Therapeutics Product Solution and Service
3.7 Date of Enter into Bone Metastasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bone Metastasis Therapeutics Breakdown Data by Type
4.1 Global Bone Metastasis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bone Metastasis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Bone Metastasis Therapeutics Breakdown Data by Application
5.1 Global Bone Metastasis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bone Metastasis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bone Metastasis Therapeutics Market Size (2016-2027)
6.2 North America Bone Metastasis Therapeutics Market Size by Type
6.2.1 North America Bone Metastasis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bone Metastasis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bone Metastasis Therapeutics Market Size by Type (2016-2027)
6.3 North America Bone Metastasis Therapeutics Market Size by Application
6.3.1 North America Bone Metastasis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bone Metastasis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bone Metastasis Therapeutics Market Size by Application (2016-2027)
6.4 North America Bone Metastasis Therapeutics Market Size by Country
6.4.1 North America Bone Metastasis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bone Metastasis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bone Metastasis Therapeutics Market Size (2016-2027)
7.2 Europe Bone Metastasis Therapeutics Market Size by Type
7.2.1 Europe Bone Metastasis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bone Metastasis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bone Metastasis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bone Metastasis Therapeutics Market Size by Application
7.3.1 Europe Bone Metastasis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bone Metastasis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bone Metastasis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bone Metastasis Therapeutics Market Size by Country
7.4.1 Europe Bone Metastasis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bone Metastasis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bone Metastasis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bone Metastasis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bone Metastasis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bone Metastasis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bone Metastasis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bone Metastasis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bone Metastasis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bone Metastasis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bone Metastasis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bone Metastasis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bone Metastasis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bone Metastasis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bone Metastasis Therapeutics Market Size (2016-2027)
9.2 Latin America Bone Metastasis Therapeutics Market Size by Type
9.2.1 Latin America Bone Metastasis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bone Metastasis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bone Metastasis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bone Metastasis Therapeutics Market Size by Application
9.3.1 Latin America Bone Metastasis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bone Metastasis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bone Metastasis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bone Metastasis Therapeutics Market Size by Country
9.4.1 Latin America Bone Metastasis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bone Metastasis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bone Metastasis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bone Metastasis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bone Metastasis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bone Metastasis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bone Metastasis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bone Metastasis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bone Metastasis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bone Metastasis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bone Metastasis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bone Metastasis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bone Metastasis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bone Metastasis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Bone Metastasis Therapeutics Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Bone Metastasis Therapeutics Introduction
11.2.4 Bayer Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Bone Metastasis Therapeutics Introduction
11.3.4 Merck Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bone Metastasis Therapeutics Introduction
11.4.4 Pfizer Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Bone Metastasis Therapeutics Introduction
11.5.4 Novartis Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Bone Metastasis Therapeutics Introduction
11.6.4 Amgen Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Pharmalucence
11.7.1 Pharmalucence Company Details
11.7.2 Pharmalucence Business Overview
11.7.3 Pharmalucence Bone Metastasis Therapeutics Introduction
11.7.4 Pharmalucence Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.7.5 Pharmalucence Recent Development
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Details
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Bone Metastasis Therapeutics Introduction
11.8.4 Fresenius Kabi Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.8.5 Fresenius Kabi Recent Development
11.9 Omega Laboratories
11.9.1 Omega Laboratories Company Details
11.9.2 Omega Laboratories Business Overview
11.9.3 Omega Laboratories Bone Metastasis Therapeutics Introduction
11.9.4 Omega Laboratories Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.9.5 Omega Laboratories Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Bone Metastasis Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Bone Metastasis Therapeutics Business (2016-2021)
11.10.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bone Metastasis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Tumor Ablation Therapy
Table 4. Key Players of Surgery
Table 5. Global Bone Metastasis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bone Metastasis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bone Metastasis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bone Metastasis Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Bone Metastasis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bone Metastasis Therapeutics Market Share by Regions (2022-2027)
Table 11. Bone Metastasis Therapeutics Market Trends
Table 12. Bone Metastasis Therapeutics Market Drivers
Table 13. Bone Metastasis Therapeutics Market Challenges
Table 14. Bone Metastasis Therapeutics Market Restraints
Table 15. Global Bone Metastasis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bone Metastasis Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Bone Metastasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Metastasis Therapeutics as of 2020)
Table 18. Ranking of Global Top Bone Metastasis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bone Metastasis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bone Metastasis Therapeutics Product Solution and Service
Table 22. Date of Enter into Bone Metastasis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bone Metastasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bone Metastasis Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Bone Metastasis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bone Metastasis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bone Metastasis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bone Metastasis Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Bone Metastasis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bone Metastasis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bone Metastasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bone Metastasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bone Metastasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bone Metastasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bone Metastasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bone Metastasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bone Metastasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bone Metastasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bone Metastasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bone Metastasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bone Metastasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bone Metastasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bone Metastasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bone Metastasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bone Metastasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bone Metastasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bone Metastasis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bone Metastasis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bone Metastasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bone Metastasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bone Metastasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bone Metastasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bone Metastasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bone Metastasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bone Metastasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bone Metastasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bone Metastasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bone Metastasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bone Metastasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bone Metastasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. F. Hoffmann-La Roche Company Details
Table 63. F. Hoffmann-La Roche Business Overview
Table 64. F. Hoffmann-La Roche Bone Metastasis Therapeutics Product
Table 65. F. Hoffmann-La Roche Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 66. F. Hoffmann-La Roche Recent Development
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Bone Metastasis Therapeutics Product
Table 70. Bayer Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Bone Metastasis Therapeutics Product
Table 75. Merck Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Bone Metastasis Therapeutics Product
Table 80. Pfizer Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Bone Metastasis Therapeutics Product
Table 85. Novartis Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Bone Metastasis Therapeutics Product
Table 90. Amgen Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Pharmalucence Company Details
Table 93. Pharmalucence Business Overview
Table 94. Pharmalucence Bone Metastasis Therapeutics Product
Table 95. Pharmalucence Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Pharmalucence Recent Development
Table 97. Fresenius Kabi Company Details
Table 98. Fresenius Kabi Business Overview
Table 99. Fresenius Kabi Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Fresenius Kabi Recent Development
Table 101. Omega Laboratories Company Details
Table 102. Omega Laboratories Business Overview
Table 103. Omega Laboratories Bone Metastasis Therapeutics Product
Table 104. Omega Laboratories Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Omega Laboratories Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Bone Metastasis Therapeutics Product
Table 109. Eli Lilly Revenue in Bone Metastasis Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone Metastasis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Tumor Ablation Therapy Features
Figure 4. Surgery Features
Figure 5. Global Bone Metastasis Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Cancer Rehabilitation Centers Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Bone Metastasis Therapeutics Report Years Considered
Figure 11. Global Bone Metastasis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bone Metastasis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bone Metastasis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Bone Metastasis Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Bone Metastasis Therapeutics Market Share by Players in 2020
Figure 16. Global Top Bone Metastasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Metastasis Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bone Metastasis Therapeutics Revenue in 2020
Figure 18. Global Bone Metastasis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Bone Metastasis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bone Metastasis Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Bone Metastasis Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Bone Metastasis Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bone Metastasis Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Bone Metastasis Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Bone Metastasis Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bone Metastasis Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bone Metastasis Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bone Metastasis Therapeutics Market Share by Region (2016-2027)
Figure 40. China Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bone Metastasis Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Bone Metastasis Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Bone Metastasis Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bone Metastasis Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bone Metastasis Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bone Metastasis Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bone Metastasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 65. Pharmalucence Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 66. Fresenius Kabi Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 67. Omega Laboratories Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 68. Eli Lilly Revenue Growth Rate in Bone Metastasis Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---